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Amphiphilic substances may stimulate cellular events through
direct activation of G-proteins. The present experiments indicate
that several amphiphilic sweeteners and the bitter tastant, quin-
ine, activate transducin and G1/G.-proteins. Concentrations of
INTRODUCTION
G-proteins transfer and amplify signals between specific receptors
and effectors through the exchange of GDP for GTP [1,2]. G-
protein activation is terminated by the hydrolysis of GTP to
GDP and P1 through the intrinsic GTPase activity of the a-
subunits [3,4]. Recent studies have shown that a variety of
cationic-amphiphilic neuropeptides and venom peptides
(e.g. substance P, bradykinin and mastoparan) and non-peptide
substances (e.g. compound 48/80 and alkylamines) activate G-
proteins directly [5-7]. The amphiphilic properties of such
compounds allow them to penetrate deeply into the plasma
membrane, as predicted by Schwyzer's theory of insertion of
amphiphilic peptides into membranes [8]. As the interaction of
receptor molecules with G-proteins appears to be mediated by
the third cytoplasmic loop ofreceptor proteins [5-7], it is assumed
that amphiphilic peptides mimic receptor activities by interaction
with G-proteins in a similar manner as receptors do. Hence, by
their direct activation of G-proteins, amphiphilic substances may
mimic certain cellular effects of receptor agonist. The physio-
logical significance of such a signal-transduction pathway is not
known at the present time.
Taste sensation is initiated by an interaction of taste stimuli
with the exposed apical surface of the taste receptor cells, leading
to membrane depolarization and synaptic transmission to
second-order neurons [9]. In contrast with ionic stimuli (salt and
sour), the transduction of sweet and bitter tastes has been
proposed to involve putative specific membrane receptors [10].
Recent studies using PCR in rat lingual epithelia or bovine taste
tissue [11,12] have identified novel G-protein-coupled receptors.
However, it is not yet known whether these receptors are involved
in taste transduction and, to date, no taste receptor has been
isolated. Furthermore, multiple transduction mechanisms may
be operative for both sweet and bitter tastes [13-16]. Hydrophobic
interactions of bitter stimuli with lipid bilayers of gustatory
tissue has led to the hypothesis that specific receptors are not
needed for bitter sensation [17]. Indeed, bitter stimuli can
depolarize N- 18 mouse neuroblastoma cells, unrelated to taste
[18]. Recently [16] it has been hypothesized that direct activation
ofG-proteins by amphiphilic and potentially bitter neuropeptides
(e.g. bradykinin is bitter) is one of the diverse signal-transduction
pathways for bitter sensation.
The involvement of G-proteins and intracellular signal mole-
taste substances required to activate G-proteins in vitro correlated
with those used to elicit taste. These data support the hypothesis
that amphiphilic taste substances may elicit taste through direct
activation of G-proteins.
cules in mediation of sweet and bitter taste transduction has been
shown [13,14,19,20]. Moreover, gustducin, a novel G-protein
closely related to transducin (the major G-protein of the retina),
has been identified and cloned from rat gustatory tissue [21].
Interestingly, transducin is also present in gustatory tissue [22].
These findings call for common routes of G-proteins in the senses
of vision and taste.
Intriguingly, it has been shown that intravenous and intra-
lingual administration of some non-sugar sweeteners may elicit
taste [23,24] and taste nerve responses [25,26] independently of
any interaction with putative receptors at the apical surface of
the tongue. Since non-sugar sweeteners and bitter substances are
amphiphilic, and as their hydrophobic characteristics are im-
portant for their taste potency [27-29], we undertook this study
to test the hypothesis that such compounds are direct G-protein
activators. With the lack of availability of gustducin in amounts
needed for this study, we studied the effects of some known sweet
and bitter taste substances on the GTPase activity of transducin
and on a purified fraction containing G,/G.-proteins which
belong to the same G-protein superfamily [1,2]. Mastoparan was
used as a positive control for G-protein activation.
MATERIALS AND METHODS
Materials
Azolectin, mastoparan and the taste substances, sodium sac-
charin, sodium cyclamate, aspartame, neohesperidin dihydro-
chalcone (NHD), naringin, quinine chloride (hydrochloride) and
sucrose, were purchased from Sigma Chemical Co. (St. Louis,
MO, U.S.A.). Monellin was purchased from BioResources
International (Somerset, NJ, U.S.A.). Single-chain monellin was
kindly provided by Kirin Brewery Co. (Kanagawa, Japan). The
guanidine SC-45647 sweetener was kindly given by The Nutra-
Sweet Company (Mt. Prospect, IL, U.S.A.). Guanosine 5'-
[y-[35S]thio]triphosphate ([35S]GTP[S]) (1195/mmol) was pur-
chased from du Pont New England Nuclear (Bad Homburg,
Germany). Materials used for the GTPase assay were as described
elsewhere [30].
PurIfication of G-proteins
G,/G.-proteins were purified from bovine brain membranes by a
three-step column-chromatography procedure [31]. In brief,
Abbreviations used: NHD, neohesperidin dihydrochalcone; GTP[S], guanosine 5'-[y-thio]triphosphate; EC50, concentration giving half-maximal
stimulation; DMSO, dimethyl sulphoxide.
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cholate extracts were subjected to chromatography on a DEAE-
Sepharose Fast Flow column (Pharmacia, Freiburg, Germany),
AcA 34 gel filtration (Serva, Heidelberg, Germany) and on a
heptylamine-Sepharose column. Fractions were analysed for
GTP[S] binding and immunoreactivity employing specific anti-
bodies [32]. Heterotrimeric G-proteins were identified by SDS/
PAGE and silver staining. Purity was greater than 900%. The
purified mixture contained mostly Go1, some G02, Gil, Gi2, and
traces of Gi3.
Heterotrimeric transducin was prepared essentially as de-
scribed previously [33]. Heterotrimeric transducin was identified
by SDS/PAGE followed by Coomassie Blue and immuno-
staining, and quantified by GTP[S] binding. Purity was greater
than 90 %. Both the transducin and the Gi/G.-protein prepar-
ations were free of ATPase or low-affinity GTPase activities.
Reconstitution of G,/G.-proteins into phospholipid vesicles
Azolectin/cholate mixtures, 1 and 10% (w/v) respectively, in the
buffer A, and G,/G.-proteins (28 pmol) were loaded on to a
10 ml gel-filtration AcA 34 (25 cm x 8.5 mm) column prepared
with degassed buffer A containing 100 mM NaCl, 2 mM MgCl2,
1 mM EDTA and 20 mM Hepes/NaOH, pH 8.0,4 °C, according
to [34] with slight modifications. Liposomes containing Gi/Go-
proteins were eluted (200 ,ul fractions) from the column with the
above buffer and were quantified by GTP[S] binding. Pooled
fractions were then used for the GTPase assays.
GTPase assay
GTP hydrolysis was determined essentially as described by
Wenzel-Seifert and Seifert [30]. In agreement with a model
suggested by Wieland et al. [35], GDP was included in reaction
mixtures, unless otherwise specified, to enhance the relative
stimulatory effects of taste substances on GTPase activity. For
solubilized G1/Go-proteins, reaction mixtures (50 ,tl) contained
44 nM of G-proteins, 1 ,tM [y-32P]GTP (0.1 ,uCi/tube), 1 mM
adenosine 5'-[/3,y-imido]triphosphate, 3 ,uM GDP, 0.1 mM
EGTA, 0.5 ,uM MgCl2, 1 mM dithiothreitol and 0.20% (w/v)
BSA in 65 mM triethanolamine/HCI, pH 7.0. Reaction mixtures
contained taste substances and mastoparan at various concen-
trations. NHD and naringin (200 mM) were solubilized first in
20% (v/v) dimethyl sulphoxide (DMSO) with a final con-
centration of 4% (v/v) DMSO (this concentration ofDMSO did
not affect basal GTPase activity). Tubes were incubated for
15 min at 25 'C. In the experiments with transducin, the release
of Pi under the above conditions was very low. Thus the reaction
mixture was modified to contain 270 nM of transducin, 25 nM
[y-32P]GTP (0.15 /tCi/tube) and 1 ,tM GDP. Tubes were in-
cubated for 5 min at 25 'C. For G1/G.-protein-reconstitution
experiments, the reaction mixture (100 ll) was modified and
contained 5 nM G,/Go-proteins, 50 nM [y-32P]GTP (0.1 ,uCi/
tube), 0.1 mM ATP, 5 mM creatine phosphate and 40,ug of
creatine kinase without GDP.
Data analyses
Results of each experiment were analysed separately by analysis
of variance, and Student's t test was used for the determination
of statistical differences (at least at P < 0.05) between basal and
stimulated G-protein activities. Experiments with each taste
substance were performed at least twice, and three or four
replicates were used for each treatment. Correlation was calcu-
lated between the minimal tastant concentration that stimulated
significantly (P < 0.05) the GTPase activity of GJ/G.-proteins
(y-axis) versus the sweetener concentration (x-axis) needed to
produce a sweet intensity level equal to that produced by 0.29 M
sucrose (commonly used as a reference) [36-38]. The level of
quinine bitter intensity was based on its mid-range bitter intensity
[39].
RESULTS AND DISCUSSION
The results of the present study indicate that some sweet and
bitter amphiphilic taste substances are effective G-protein acti-
vators in vitro (Figure 1). Taste substances activated the GTPase
of either solubilized transducin or a solubilized mixture of
purified Gi/G0-proteins in a concentration-dependent manner.
The bitter taste substance, quinine chloride, and the non-sugar
sweeteners, NHD and sodium saccharin, were the most effective
stimuli, showing stimulations of GTPase activity up to 2-3.5-
fold. By comparison, mastoparan (400 ,M) stimulated trans-
ducin and G1/G.-proteins 1.6- and 2.7-fold respectively (results
not shown). These results suggest that some taste substances may
be similarly effective and even more effective activators of G-
proteins than mastoparan.
Lower concentrations of taste stimuli were usually required to
stimulate GTPase of transducin than for the activation of G1/G,-
proteins. Activation of transducin by taste substances showed
saturation (e.g., sodium saccharin) or biphasic concentration-
response curves (e.g. quinine chloride) (see Figure 1). In most
experiments, analysis of variance resulted in high significance of
the stimulatory effects of the taste substances (P < 0.01). In the
experiments with transducin, EC50 (concn. giving half-maximal
stimulation) values of 5 mM for sodium saccharin, 1.3 mM for
NHD, 4 mM for sodium cyclamate and 4 mM for quinine
chloride were observed. The sweet protein, monellin (used up to
250,M), did not stimulate transducin, and the stimulation by
the dipeptide, aspartame, was significant (P < 0.05) only when a
concentration of 8 mM was used. With respect to the G,/G.-
proteins, a saturated concentration-response curve was observed
only for aspartame (EC50 = 7 mM). All of the six taste stimuli
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Figure 1 Stimulation of GTPase of G,/G,-proteins (0) and transducin (0)
by taste substances
Results for the sweeteners, sodium saccharin (Sacc), NHD, aspartame (APM), sodium
cyclamate (CYC), monellin (MON) and the bilter tastant, quinine chloride (Quin), are presented.
Values are the means + S.E.M. for three or four replicates of a representative experiment. When
S.E.M. bars are missing, they were too small to be shown. Basal turnover numbers of the GI/Go-
proteins and transducin were 0.07-0.08 min-' and 0.000090.00011 min- respectively.
Concentrations of stimulus are in mM, except for MON, where it is #M.
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Figure 2 Correlaton between concentrations of taste substances which
stimulated GTPase of G,/G,-proteins and those used to elici taste In humans
Correlation was calculated between the minimal tastant concentration that stimulated significantly
(P < 0.05) the GTPase activity (yaxis) versus the sweetener concentration (x-axis) needed to
produce a sweet intensity level equal to that produced by 0.29 M sucrose (commonly used as
a reference) [36-38]. The level of quinine bitter intensity was based on its mid-range bitter
intensity [39]. Abbreviations are as for Figure 1.
shown in Figure 1 significantly stimulated (at least at P < 0.05)
the GTPase activity of G,/G.-proteins. As for native monellin,
synthetic single-chain monellin (25,M) also stimulated
(P < 0.05) the GTPase of G,/G.-proteins by 25 %.
We tested some other sweet proteins as possible activators of
G-proteins. However, with the exception of purified monellin
and single-chain monellin, other proteins were heavily con-
taminated by nucleotidase activity (results not shown) and,
therefore, could not be studied. Stimulation by sodium saccharin
or sodium cyclamate of GTPase of either transducin or G1/Go-
proteins was observed independently of sodium, and the biphasic
effects of quinine chloride on GTPase were not due to a change
in pH or due to the presence of chloride (results not shown).
Initial experiments employing purified G1/Go-proteins recon-
stituted into phospholipid vesicles indicated that sodium sac-
charin (20 mM), sodium cyclamate (50 mM), NHD (10 mM),
aspartame (9 mM), and quinine chloride (10 mM), i.e., at relative
mid-range concentrations, stimulated (at least at P < 0.05)
GTPase by 23, 32, 18, 13 and 82% respectively. Mastoparan
(40 ,uM) stimulated GTPase by 83 % under the same conditions.
Could the above receptor-independent activation of G-proteins
be related to taste sensation? On the basis of the notion that
some neuropeptides which are direct activators of G-proteins
and which are potentially bitter stimuli (e.g. bradykinin tastes
bitter), Spielman et al. [16] have recently hypothesized that direct
G-protein activation is one pathway by which bitter taste is
transduced. The present experiments, though not providing direct
evidence, are the first to provide data which support
the hypothesis of such a transduction pathway and extend the
hypothesis to some non-sugar sweeteners. This pathway is likely
to co-exist with taste sensations initiated by putative taste
receptors located at the apical plasma membrane. Interestingly,
the concentrations of taste substances which increased the
GTPase activity of G,/G0 proteins and transducin correlated
closely (Figure 2) with those needed to elicit taste sensation in
humans [e.g. 26,36-39]. The slopes of the concentration-response
curves for saccharin, NHD, quinine and cyclamate activating
transducin were steepest at the low millimolar range (Figure 1).
Unspecific effects (e.g. changes in the microenvironment of G-
proteins due to the substances tested) may be ruled out, since
naringin, which is the precursor of NHD (reduction of one
oxygen in the y-ring of naringin gives NHD; see [37]), did not
stimulate, but rather slightly inhibited, the GTPase of transducin
and G,/Go-proteins when applied at the same concentrations
(results not shown). In addition, the SC-45647 guanidine sweet-
ener [40] did not increase the GTPase activity of transducin and
the G,/G. proteins. Sucrose (0.5 M) inhibited (40 %) GTPase of
GJ/GO-proteins. The mechanism for such a response is unclear.
There was a clear higher sensitivity of transducin, which is
present in gustatory tissue [22], towards stimulation by taste
substances, compared with the GJ/GO-proteins (Figure 1). The
results obtained from the reconstitution experiments suggest that
some taste substances, when applied at concentrations needed to
elicit taste, activate G-proteins associated with lipid bilayers.
With respect to possible physiological relevance of the present
experiments, it should be noted that, in order for a taste stimulus
to interact with the a-subunit of G-proteins directly under
physiological conditions, it must penetrate the plasma membrane
[5,6]. The concentrations of some taste stimuli required to elicit
taste sensation are, for nutritional reasons, quite high [e.g.,
14,38]. However, taste sensation of bitter stimuli (most are toxic
constituents which produce aversive behavioural signals) and
non-sugar sweeteners (most are synthetic) is in the low-millimolar
range [26,36-39]. These substances are amphiphilic and, as such,
they bear hydrophobic and hydrophilic domains. It is known
that the hydrophobicity of amphiphilic drugs (e.g., chlor-
promazine, imipramine, propranolol) allows these molecules to
permeate through, and to accumulate, in the plasma membrane
[41-43]. Some amphiphilic drugs get access to the surface of the
intracellular membranes to which they become absorbed. Intra-
cellularly, these substances are not evenly distributed, but may
display affinities to cellular components [42]. Such effects occur
at the millimolar concentration range, e.g. at concentrations
similar to the ones needed to elicit taste by the above taste
substances.
Non-sugar sweeteners are, as bitter stimuli, chemically diverse;
e.g., these are aromatic compounds, sulphamates, dipeptides,
guanidines and even proteins. These substances are amphiphilic,
and according to the AH-B-y sweet triangle theory of sweetness
[27-29], it is the presence of a strong y-hydrophobic binding site
in these sweeteners that is responsible for their high sweet
potency and that differentiates them from sugars, which contain
mainly the hydrophilic (AH-B) sites. By analogy to many
amphiphilic drugs [41-44], low-molecular-mass non-sugar sweet-
eners would be expected to possess the capacity to permeate
through membranes. Even the well-known sweet taste protein,
monellin, possesses hydrophobic and hydrophilic sites which
may be important for its taste [45]. Interestingly, amphiphilic
peptides may also cross membranes through a process referred to
as 'electrophoretic transfer' [46]. Of note is the recent suggestion
that receptors may interact with G-proteins through hydrophobic
domains which appear to be more important for the activation of
G-proteins than basic moieties [47]. Thus, although comprising
diverse chemical structures, non-sugar sweeteners (as well as
some bitter tastants) share amphiphilic characteristics. The rapid
entry of saccharin into the bloodstream from the stomach and
the gut, the rapid excretion (with active transport in the kidney)
in the urine [48,49], and the fast absorption of quinine and its
rapid distribution in tissues, including the fetus [50], may at least
in part, be due to their amphiphilic characteristics.
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The hypothesis that non-sugar sweeteners activate G-proteins
directly under physiological conditions is consistent with the
temporal characteristics of these compounds. Compared with
sugars, almost all non-sugar sweeteners possess inferior sweet
quality such as slow taste onset and lingering aftertaste (sweet
persistence) [51,52]. The delays in onset and extinction of
sensation may result from a process of stimulus penetration
through the plasma membrane. Furthermore, some of the above
taste compounds elicit taste [23,24] and taste nerve responses
[25,26] following intravenous or intralingual administration,
independently of stimulation of putative receptors at the apical
surface of the tongue. Fishberg et al. [23] used intravenous
injection of sodium saccharin to measure the circulation time in
humans, i.e., subjects describe a sweet taste passing rapidly from
the base to the tip of the tongue. These observations were usually
interpreted as stimulation of putative taste receptors that may
occur at the basolateral membrane of taste cells, in addition to
those at the apical surface. Moreover, we found that, in addition
to the stimulation of gustatory membranes, sodium saccharin
increased significantly adenylate cyclase activity in membranes
derived from tongue muscle, femur muscle and from liver [53].
These effects were concentration- and GTP-dependent and were
also interpreted on the basis that receptors for saccharin may
occur in other tissues. However, one may equally propose that
the lack of tissue specificity for saccharin is due to saccharin
penetrating the plasma membrane and interacting directly with
G-proteins.
In summary, the present study shows that some taste sub-
stances are direct G-protein activators. Such a transduction
pathway may especially be relevant to non-sugar sweeteners and
bitter substances which are amphiphilic. Future studies will have
to address the questions of whether the stimulatory effects by
taste substances reported herein can also be seen with expressed
gustducin and in native taste-cell membranes and which effector
systems are activated.
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